BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3370988)

  • 1. Clinical microdose study of gossypol: effect on sperm motility and renal function.
    Frick J; Aulitzky W; Kalla NR
    Contraception; 1988 Feb; 37(2):153-62. PubMed ID: 3370988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC; Jouannet P; Marson J; Soumah A
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hormone profiles and the restoration of spermatogenesis in men treated with gossypol.
    Gu ZP; Wang YX; Sang GW; Wang WC; Chen ZX; Zhao XJ; Shao QX; Jiang Y
    Int J Androl; 1990 Aug; 13(4):253-7. PubMed ID: 2117586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-dosage oral cyproterone acetate as a male contraceptive.
    Wang C; Yeung KK
    Contraception; 1980 Mar; 21(3):245-72. PubMed ID: 6771091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA; Yeung CH; Nieschlag E
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of long-term treatment with levo-norgestrel and testosterone enanthate in normal men.
    Foegh M; Nicol K; Petersen IB; Schou G
    Contraception; 1980 Jun; 21(6):631-40. PubMed ID: 6775869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with gossypol in non-Chinese men: a follow-up.
    Coutinho EM; Melo JF
    Contraception; 1988 Feb; 37(2):137-51. PubMed ID: 3286112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined use of oral medroxyprogesterone acetate and methyltestosterone in a male contraceptive trial programme.
    Bain J; Rachlis V; Robert E; Khait Z
    Contraception; 1980 Apr; 21(4):365-79. PubMed ID: 6771093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antispermatogenic action of gossypol in men.
    Coutinho EM; Melo JF; Barbosa I; Segal SJ
    Fertil Steril; 1984 Sep; 42(3):424-30. PubMed ID: 6468676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose gossypol for male contraception.
    Gu ZP; Mao BY; Wang YX; Zhang RA; Tan YZ; Chen ZX; Cao L; You GD; Segal SJ
    Asian J Androl; 2000 Dec; 2(4):283-7. PubMed ID: 11202417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gossypol as oral contraceptive for male: trial case report.
    Hoshiai H; Uehara S; Mori R; Nagaike F; Tsuiki A; Suzuki M
    Tohoku J Exp Med; 1982 Nov; 138(3):275-80. PubMed ID: 6818716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with gossypol as a male pill.
    Liu GZ; Lyle KC; Cao J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1079-81. PubMed ID: 3314523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of gossypol analogs on human sperm motility.
    Tanphaichitr N; Agulnick A; Hill JA
    Contraception; 1989 Jun; 39(6):687-97. PubMed ID: 2752755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of prostaglandin in the antifertility effects of gossypol.
    Kalla NR; Rovan E; Ranga A; Bhatia S; Frick J
    Contraception; 1986 Aug; 34(2):177-90. PubMed ID: 3465506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
    Koch UJ; Lorenz F; Danehl K; Ericsson R; Hasan SH; Keyserlingk DV; Lübke K; Mehring M; Römmler A; Schwartz U; Hammerstein J
    Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation.
    Bastias MC; Kamijo H; Pavlou SN
    Fertil Steril; 1993 Jun; 59(6):1261-5. PubMed ID: 8495775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of gossypol on human sperm motility: relationship with time, temperature and concentration.
    Hong CY; Huang JJ; Wu P
    Hum Toxicol; 1989 Jan; 8(1):49-51. PubMed ID: 2714811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is high dosage testosterone an effective male contraceptive agent?
    Matsumoto AM
    Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men.
    Yang ZJ; Ye WS; Cui GH; Guo Y; Xue SP
    Contraception; 2004 Sep; 70(3):203-11. PubMed ID: 15325889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.